安徽发布对医药商业贿赂案件进行信用评级处置企业名单,含益佰制药、华润医药等

财中社
Jun 20

6月18日,安徽省医药价格和集中采购中心发布公告称,已对2024年第一、二季度医药商业贿赂案件进行信用评级处置,通知25家医药企业领取《价格招采信用评价评级函》。公告附件显示,需要领取评级函的企业中包含多家上市公司及其关联公司,涉及益佰制药(600594)及华润医药(03320)、海王生物(000078)旗下子公司。《财中社》注意到,安徽海王国安医药系上市公司海王生物旗下企业,华润安徽医药与华润...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10